Here's the live share price of Eris Lifesciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Eris Lifesciences has gained 22.67% CAGR. Over the past year, the corresponding return has been 11.08%.
Eris Lifesciences’s current P/E of 51.42x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Eris Lifesciences | -2.45 | 0.22 | -4.76 | -12.15 | 11.08 | 33.16 | 22.67 |
| Sun Pharmaceutical Industries | 0.32 | 1.60 | 10.60 | 8.68 | 0.14 | 21.96 | 25.69 |
| Divi's Laboratories | -0.03 | -3.56 | 3.97 | -3.76 | 7.56 | 23.41 | 10.46 |
| Torrent Pharmaceuticals | -0.96 | -1.58 | 6.01 | 15.51 | 11.14 | 33.01 | 22.19 |
| Cipla | 0.56 | -2.53 | -3.96 | -0.40 | 3.24 | 10.95 | 13.84 |
| Dr. Reddy's Laboratories | 1.59 | 2.13 | -3.05 | -3.64 | 1.84 | 13.05 | 4.60 |
| Lupin | 2.66 | 2.83 | 3.87 | 8.55 | 3.12 | 42.53 | 16.80 |
| Zydus Lifesciences | -0.63 | -1.76 | -11.31 | -4.28 | -5.33 | 30.89 | 14.08 |
| Mankind Pharma | -1.74 | -6.00 | -17.85 | -10.30 | -20.70 | 14.01 | 8.18 |
| Aurobindo Pharma | 1.51 | -3.89 | 8.47 | 7.17 | -2.01 | 39.53 | 6.40 |
| Alkem Laboratories | 0.29 | -1.90 | 2.54 | 16.65 | 4.19 | 23.22 | 13.84 |
| Abbott India | -1.25 | -6.50 | -10.56 | -12.97 | -1.18 | 9.86 | 11.43 |
| Glenmark Pharmaceuticals | -0.48 | 4.17 | -4.83 | 17.52 | 28.48 | 67.13 | 30.30 |
| Laurus Labs | -0.88 | -1.28 | 12.95 | 52.78 | 76.64 | 37.55 | 24.16 |
| Biocon | 2.02 | -8.24 | 9.09 | 9.66 | 10.19 | 13.70 | -3.45 |
| GlaxoSmithKline Pharmaceuticals | -0.44 | 3.57 | -5.68 | -20.67 | 13.92 | 24.68 | 10.23 |
| Anthem Biosciences | 3.03 | -0.26 | -23.13 | -9.12 | -9.12 | -3.14 | -1.89 |
| Ipca Laboratories | -5.00 | -4.91 | 6.04 | 2.52 | -10.70 | 17.64 | 5.16 |
| Ajanta Pharma | -1.89 | 4.06 | 1.69 | 2.29 | -9.32 | 30.31 | 18.76 |
| J B Chemicals & Pharmaceuticals | -1.77 | -2.36 | 5.02 | 3.09 | -2.66 | 20.00 | 26.95 |
Over the last one year, Eris Lifesciences has gained 11.08% compared to peers like Sun Pharmaceutical Industries (0.14%), Divi's Laboratories (7.56%), Torrent Pharmaceuticals (11.14%). From a 5 year perspective, Eris Lifesciences has outperformed peers relative to Sun Pharmaceutical Industries (25.69%) and Divi's Laboratories (10.46%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,602.04 | 1,579.18 |
| 10 | 1,583.99 | 1,585.89 |
| 20 | 1,604.01 | 1,591.66 |
| 50 | 1,598.18 | 1,606.53 |
| 100 | 1,660.91 | 1,615.15 |
| 200 | 1,578.95 | 1,563.57 |
In the latest quarter, Eris Lifesciences saw a rise in promoter holding to 54.84%, while DII stake increased to 19.36%, FII holding fell to 7.21%, and public shareholding moved down to 18.57% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 64,82,100 | 2.72 | 1,034.15 | |
| 24,59,629 | 1.59 | 392.41 | |
| 18,66,828 | 2.2 | 297.83 | |
| 12,30,000 | 1.15 | 196.23 | |
| 12,24,569 | 0.98 | 195.37 | |
| 12,17,751 | 0.76 | 194.28 | |
| 7,71,388 | 1.48 | 123.07 | |
| 6,75,000 | 0.37 | 107.69 | |
| 6,75,000 | 0.54 | 107.69 | |
| 6,43,678 | 0.85 | 102.69 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Dec 15, 2025, 9:46 PM IST | Eris Lifesciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Dec 10, 2025, 7:28 PM IST | Eris Lifesciences - Clarification With Respect To Increase In Volume |
| Dec 10, 2025, 5:23 PM IST | Eris Lifesciences - Clarification sought from Eris Lifesciences Ltd |
| Dec 06, 2025, 12:01 AM IST | Eris Lifesciences - Corrigendum To The Notice Of Postal Ballot Dated November 24, 2025 |
| Dec 03, 2025, 9:27 PM IST | Eris Lifesciences - Corporate Presentation |
Eris Lifesciences Ltd. is a Public Limited Listed company incorporated on 25/01/2007 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24232GJ2007PLC049867 and registration number is 049867. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1697.75 Cr. and Equity Capital is Rs. 13.62 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Eris Lifesciences is ₹1,569.00 as on Dec 17, 2025.
The Eris Lifesciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
The market cap of Eris Lifesciences is ₹21,372.43 Cr as on Dec 17, 2025.
Today’s highest and lowest price of Eris Lifesciences are ₹1,574.10 and ₹1,549.35.
The 52-week high/low is the highest and lowest price at which Eris Lifesciences stock has traded in the past 52-week or nearly a year. The 52-week high of Eris Lifesciences is ₹1,909.55 and 52-week low of Eris Lifesciences is ₹1,130.05 as on Dec 17, 2025.
The Eris Lifesciences has shown returns of 0.71% over the past day, 0.22% for the past month, -4.76% over 3 months, 11.08% over 1 year, 33.16% across 3 years, and 22.67% over 5 years.
P/E ratio of and PB ratio of Eris Lifesciences are 51.42 and 7.71 on Dec 17, 2025. While the company gives a dividend yield of 0.47 per annum.